(Total Views: 441)
Posted On: 02/26/2021 11:43:01 AM
Post# of 148884
I know that I'm thinking outside of the box here, but I think that the FDA should have approved leronlimab after the initial eIND results and before and instead of requiring a Phase 2b/3 clinical trial in which they knew they were sentencing some people to sure death. They must have known already what dosage to give - whether 350 mg or 700 mg. And they knew that LL has an impeccable safety profile. That's why I say barbarism.
"Anecdotes don't come off life support."
Russia didn't require a lengthy clinical trial before approving their vaccine for use.
Wasn't it said that the FDA needed only to see the raw data before approving LL for Emergency Use Authorization - Emergency Use Authorization?
"Yes, and how many times must a man look up
Before he can see the sky?
And how many ears must one man have
Before he can hear people cry?
Yes, and how many deaths will it take 'til he knows
That too many people have died?"
Bob Dylan, 1962
"Anecdotes don't come off life support."
Russia didn't require a lengthy clinical trial before approving their vaccine for use.
Wasn't it said that the FDA needed only to see the raw data before approving LL for Emergency Use Authorization - Emergency Use Authorization?
"Yes, and how many times must a man look up
Before he can see the sky?
And how many ears must one man have
Before he can hear people cry?
Yes, and how many deaths will it take 'til he knows
That too many people have died?"
Bob Dylan, 1962
(5)
(0)Scroll down for more posts ▼
